EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Determinants of hyperinsulinism severity in children with Beckwith-Wiedemann syndrome

Andrew M George iD, Aravind Viswanathan iD, Jonathan H Sussman iD, Evan R Hathaway, Abigail Casalnova, Salima Nesbitt, Kara E Boodhansingh, Nicole M Stewart, Heather J McKnight, Katherine Lord, Diva D De León, Charles A Stanley und 3 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Andrew M George und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome, Congenital Hyperinsulinism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Victoria Fertitta Fund, Beckwith-Wiedemann Syndrome Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Congenital hyperinsulinism (HI) is a serious clinical feature of Beckwith-Wiedemann syndrome (BWS) causing severe hypoglycemia. The relationship between BWS genotypes and HI severity is not well understood.

Objective

Investigate the relationship between molecular determinants of patients with BWS and HI with measures of HI severity.

Methods

This retrospective cohort study included 85 children from 2009-2024, all patients evaluated at single, tertiary care center. BWS genotype frequency included 41 children with pUPD11, 24 with IC2 LOM, 8 with 11p15 chromosomal anomalies, 6 with GWpUPD, 4 with IC1 GOM, and 2 with CDKN1C. Retrospectively reviewed interventions included maximum glucose infusion rate (max GIR), diazoxide responsiveness, and surgery. Primary outcome was association between BWS genotypes and measures of HI severity. Secondary outcomes included the relationship between pUPD11 length and presence of KATP variants with diazoxide responsiveness and surgical need.

Results

Significant differences presented among genotypes in max GIR (P = .004), enteral dextrose requirements (P = .029), and pancreatectomy (P = .012). Most patients with IC2 LOM, IC1 GOM or CDKN1C were diazoxide responsive and did not require surgery. Patients with pUPD11 were more likely to be diazoxide unresponsive and to require surgery, especially if pUPD11 length extended into the KATP gene region and if a pathogenic variant in the ABCC8 or KCNJ11 was present.

Conclusion

Patients with pUPD11 experience more severe HI, while patients with IC2 LOM, IC1 GOM, and CDKN1C exhibit milder disease. Based on our findings, we designed a genetic testing algorithm to guide clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Beckwith-Wiedemann SyndromeCongenital HyperinsulinismHumansRetrospective StudiesFemaleMaleSeverity of Illness IndexGenotypeInfantChild, PreschoolDiazoxideInfant, NewbornPancreatectomy

Stichwörter der Autor:innen

Beckwith-Wiedemann syndromediazoxidehyperinsulinismhypoglycemiainsulinpancreatectomy

Substanzen

Diazoxide

Autor:innen und Institutionen

  • Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Congenital Hyperinsulinism Center, Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Surgery, The Children's Hospital of Philadelphia and the Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Andrew M George, Aravind Viswanathan, Jonathan H Sussman, Arupa Ganguly, Jennifer M Kalish

Förderung

  • Victoria Fertitta Fund
  • Beckwith-Wiedemann Syndrome Research

Zitieren

APA

George, A. M., Viswanathan, A., Sussman, J. H., Hathaway, E. R., Casalnova, A., Nesbitt, S., Boodhansingh, K. E., Stewart, N. M., McKnight, H. J., Lord, K., De León, D. D., Stanley, C. A., Adzick, N. S., Ganguly, A., & Kalish, J. M. (2026). Determinants of hyperinsulinism severity in children with Beckwith-Wiedemann syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag053

Vancouver

George AM, Viswanathan A, Sussman JH, Hathaway ER, Casalnova A, Nesbitt S, et al. Determinants of hyperinsulinism severity in children with Beckwith-Wiedemann syndrome. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag053

BibTeX
@article{George2026,
  author = {George, Andrew M and Viswanathan, Aravind and Sussman, Jonathan H and Hathaway, Evan R and Casalnova, Abigail and Nesbitt, Salima and Boodhansingh, Kara E and Stewart, Nicole M and McKnight, Heather J and Lord, Katherine and De León, Diva D and Stanley, Charles A and Adzick, N Scott and Ganguly, Arupa and Kalish, Jennifer M},
  title = {Determinants of hyperinsulinism severity in children with Beckwith-Wiedemann syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag053}
}
Kostenlos starten →